Total Payments
$17,151
2022 Payments
$138.78
Companies
10
Transactions
36
Medicare Patients
2,186
Medicare Billing
$343,360
Payment Breakdown by Category
Consulting$7,583 (44.2%)
Other$6,285 (36.6%)
Travel$2,277 (13.3%)
Food & Beverage$918.29 (5.4%)
Education$88.04 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $7,583 | 3 | 44.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,285 | 2 | 36.6% |
| Travel and Lodging | $2,277 | 8 | 13.3% |
| Food and Beverage | $918.29 | 19 | 5.4% |
| Education | $88.04 | 4 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $4,654 | 9 | $0 (2019) |
| Exelixis Inc. | $4,647 | 8 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $3,588 | 9 | $0 (2018) |
| Seattle Genetics, Inc. | $2,395 | 4 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $1,500 | 1 | $0 (2021) |
| Dendreon Pharmaceuticals LLC | $161.96 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $138.78 | 1 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $39.14 | 1 | $0 (2018) |
| PFIZER INC. | $14.63 | 1 | $0 (2018) |
| Janssen Biotech, Inc. | $12.25 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $138.78 | 1 | Novartis Pharmaceuticals Corporation ($138.78) |
| 2021 | $1,500 | 1 | Merck Sharp & Dohme Corporation ($1,500) |
| 2019 | $4,827 | 11 | E.R. Squibb & Sons, L.L.C. ($4,654) |
| 2018 | $10,641 | 22 | Exelixis Inc. ($4,591) |
| 2017 | $44.15 | 1 | Exelixis Inc. ($44.15) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/05/2022 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $138.78 | General |
| 01/04/2021 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 11/12/2019 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $161.96 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/06/2019 | Exelixis Inc. | Cabometyx (Drug) | Education | In-kind items and services | $11.60 | General |
| Category: Oncology | ||||||
| 07/22/2019 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $3,382.50 | General |
| 07/19/2019 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $15.00 | General |
| 06/22/2019 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $60.00 | General |
| 06/22/2019 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| 06/22/2019 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $30.00 | General |
| 06/22/2019 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $29.99 | General |
| 06/21/2019 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $759.96 | General |
| 06/21/2019 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $201.38 | General |
| 06/21/2019 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $124.84 | General |
| 11/09/2018 | Exelixis Inc. | Cabometyx (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,960.00 | General |
| Category: Oncology | ||||||
| 11/09/2018 | Exelixis Inc. | Cabometyx (Drug) | Travel and Lodging | In-kind items and services | $278.40 | General |
| Category: Oncology | ||||||
| 11/09/2018 | Exelixis Inc. | Cabometyx (Drug) | Travel and Lodging | In-kind items and services | $247.47 | General |
| Category: Oncology | ||||||
| 11/09/2018 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $57.87 | General |
| Category: Oncology | ||||||
| 11/09/2018 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Oncology | ||||||
| 09/13/2018 | Seattle Genetics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,325.00 | General |
| 09/13/2018 | Seattle Genetics, Inc. | — | Food and Beverage | In-kind items and services | $25.11 | General |
| 09/13/2018 | Seattle Genetics, Inc. | — | Food and Beverage | In-kind items and services | $23.25 | General |
| 09/13/2018 | Seattle Genetics, Inc. | — | Food and Beverage | In-kind items and services | $22.02 | General |
| 09/06/2018 | Janssen Biotech, Inc. | Erleada (Drug), DARZALEX | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: Oncology | ||||||
| 08/16/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 08/14/2018 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Consulting Fee | Cash or cash equivalent | $2,700.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 634 | 1,215 | $240,510 | $97,668 |
| 2022 | 9 | 587 | 1,109 | $190,234 | $87,446 |
| 2021 | 6 | 538 | 1,158 | $191,060 | $98,697 |
| 2020 | 5 | 427 | 908 | $142,210 | $59,549 |
Total Patients
2,186
Total Services
4,390
Medicare Billing
$343,360
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 262 | 596 | $108,292 | $40,498 | 37.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 158 | 386 | $80,390 | $39,791 | 49.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 83 | $11,403 | $3,581 | 31.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $8,170 | $3,065 | 37.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 20 | $8,508 | $2,650 | 31.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 26 | $8,280 | $2,576 | 31.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $6,848 | $2,428 | 35.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 20 | 24 | $4,320 | $1,703 | 39.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $3,037 | $875.98 | 28.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 11 | 11 | $1,262 | $500.47 | 39.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 260 | 639 | $100,787 | $44,109 | 43.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 111 | 230 | $39,504 | $24,647 | 62.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 32 | 32 | $9,760 | $4,487 | 46.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 30 | 30 | $14,250 | $4,151 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 80 | 99 | $13,328 | $4,076 | 30.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 26 | 29 | $2,755 | $2,080 | 75.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $3,606 | $1,549 | 42.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 14 | $4,900 | $1,430 | 29.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 19 | 21 | $1,344 | $917.72 | 68.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 264 | 675 | $103,665 | $48,988 | 47.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 123 | 322 | $53,556 | $35,742 | 66.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 65 | 65 | $19,306 | $8,916 | 46.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 56 | 64 | $8,412 | $2,762 | 32.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 15 | 15 | $5,131 | $1,566 | 30.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 15 | 17 | $990.00 | $722.15 | 72.9% |
About Rahul Parikh, MD, PHD
Rahul Parikh, MD, PHD is a Hematology & Oncology healthcare provider based in Westwood, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2008. The National Provider Identifier (NPI) number assigned to this provider is 1629232913.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rahul Parikh, MD, PHD has received a total of $17,151 in payments from pharmaceutical and medical device companies, with $138.78 received in 2022. These payments were reported across 36 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($7,583).
As a Medicare-enrolled provider, Parikh has provided services to 2,186 Medicare beneficiaries, totaling 4,390 services with total Medicare billing of $343,360. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Internal Medicine, Hematology & Oncology
- Location Westwood, KS
- Active Since 07/15/2008
- Last Updated 10/08/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1629232913
Products in Payments
- Cabometyx (Drug) $4,647
- IMFINZI (Drug) $3,588
- PROVENGE (Drug) $161.96
- Erleada (Drug) $51.39
- XTANDI (Drug) $14.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Westwood
Gary Doolittle, M.d, M.D
Hematology & Oncology — Payments: $191,858
Hematology & Oncology $191,858
Priyanka Sharma, M.d, M.D
Hematology & Oncology — Payments: $147,730
Hematology & Oncology $147,730
Sunil Abhyankar, M.d, M.D
Hematology & Oncology — Payments: $94,271
Hematology & Oncology $94,271
Dr. Prakash Neupane, M.d, M.D
Hematology & Oncology — Payments: $57,319
Hematology & Oncology $57,319
Qamar Khan, M.d, M.D
Hematology & Oncology — Payments: $53,566
Hematology & Oncology $53,566
Ms. Leyla Shune, Md, MD
Hematology & Oncology — Payments: $18,671
Hematology & Oncology $18,671